Companies / Spyre Therapeutics, Inc. / Activity

Activity — Spyre Therapeutics, Inc.

64 moves.

Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
InsidersInstitutions
DateActorActionSecurityValueShares ΔPosition afterImpact
Q2 2026
as of
The PNC Financial Services Group, Inc.
13F manager
AddCommon stock$73.5K+828
+962.79%
914
<0.01% of shares
low
Q1 2026
as of
Bank of New York Mellon Corp/The
13F manager
TrimCommon stock$-72.4K-1K
-0.74%
191,395
0.22% of shares
low
Q1 2026
as of
Royal Bank of Canada
13F manager
AddCommon stock$63.7K+1K
+63.48%
3,250
<0.01% of shares
low
Q2 2025
as of
Barclays PLC
13F manager
AddCommon stock$30.5K+2K
+0.95%
216,646
0.25% of shares
low
Q1 2026
as of
Sterling Capital Management LLC
13F manager
TrimCommon stock$-28.2K-559
-34.72%
1,051
<0.01% of shares
low
Q1 2024
as of
Barclays PLC
13F manager
AddCommon stock$17.6K+464
+1.02%
45,962
0.05% of shares
low
Q2 2026
as of
Meeder Asset Management Inc
13F manager
TrimCommon stock$-13.4K-151
-83.43%
30
<0.01% of shares
low
Q2 2026
as of
Gf Fund Management Co. Ltd.
13F manager
AddCommon stock$12.5K+141
+9.26%
1,664
<0.01% of shares
low
Q1 2026
as of
ALPS Advisors, Inc.
13F manager
AddCommon stock$11.7K+231
+0.36%
63,939
0.07% of shares
low
Q1 2026
as of
MAI Capital Management
13F manager
NewCommon stock$656+13
13
<0.01% of shares
low
Q1 2026
as of
SG Americas Securities, LLC
13F manager
TrimCommon stock$-502-10K
-42.61%
13,396
0.02% of shares
low
Q1 2026
as of
MassMutual Private Wealth & Trust, FSB
13F manager
NewCommon stock$151+3
3
<0.01% of shares
low
Q2 2026
as of
SG Americas Securities, LLC
13F manager
TrimCommon stock$-59-669
-4.99%
12,727
0.01% of shares
low
Q2 2026
as of
Covestor Ltd
13F manager
AddCommon stock$1+7
+116.67%
13
<0.01% of shares
low
← PrevPage 2 of 2Next →